Radical Hysterectomy in Cervical Neuroendocrine Carcinoma with Michael Frumovitz

BMJ talk medicine

BMJ talk medicine and BMJ Group에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 BMJ talk medicine and BMJ Group 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

3y ago 34:13

MP3•에피소드 홈

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Michael Frumovitz to discuss radical hysterectomy in cervical neuroendocrine carcinoma. Dr. Frumovitz is an Associate Editor for IJGC and the author of the Lead Article of the April 2021 issue of IJGC, “Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study" (https://ijgc.bmj.com/content/early/2021/03/09/ijgc-2020-002213). Highlights: 1. Patients with clinical and radiologic stage I high grade neuroendocrine carcinoma of the cervix will have microscopic parametrial involvement 10% of the time 2. All patients with parametrial involvement will have other risk factors requiring postoperative radiation (positive nodes or Sedlis) 3. If a patient has negative nodes, the risk of parametrial involvement is only 3% 4. Eighty percent of recurrences will happen within first two years and 86% destined to recur will recur within 3 years

4250 에피소드